User:Mr. Ibrahem/Riociguat

Riociguat, sold under the brand name Adempas is a medication used to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). It is a second line treatment. It is taken by mouth.

Common side effects include headache, upset stomach, nausea, and diarrhea. Other side effects may include bleeding and low blood pressure. Use in pregnancy may harm the baby. It is a stimulator of soluble guanylate cyclase (sGC).

Riociguat was approved for medical use in the United States in 2013. In the United Kingdom it costs the NHS about £2,000 for 4 weeks as of 2021. This amount in the United States costs about 9,500 USD.